Identifying optimal approaches to early termination in two-stage biomarker validation studies (Q6645757)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Identifying optimal approaches to early termination in two-stage biomarker validation studies |
scientific article; zbMATH DE number 7951425
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identifying optimal approaches to early termination in two-stage biomarker validation studies |
scientific article; zbMATH DE number 7951425 |
Statements
Identifying optimal approaches to early termination in two-stage biomarker validation studies (English)
0 references
29 November 2024
0 references
diagnostic biomarkers
0 references
group sequential testing
0 references
optimal designs
0 references
prostate cancer
0 references
